Thursday, November 17, 2011

FDA approves clobazam

The FDA has approved clobazam (Onfi) for add-on use in patients with Lennox-Gastaut syndrome.  Given clobazam's safety record internationally, that's got to be good news for those patients.

 

The FDA has approved clobazam (Onfi) for add-on use in patients with Lennox-Gastaut syndrome.  Given clobazam's safety record internationally, that's got to be good news for those patients.   ...

No comments:

Post a Comment